model |  | B | SE(B) | β | t | 95% CI | p | R2 |
---|---|---|---|---|---|---|---|---|
(a) Sclerostin as dependent variable | ||||||||
 1 | Sexa | 24.14 | 2.56 | 0.52 | 9.40 | (19.08~29.20) | < 0.001 | 0.267 |
 2 | Sexa | 23.13 | 2.50 | 0.49 | 9.24 | (18.20~28.06) | < 0.001 | 0.311 |
Age | 0.58 | 0.14 | 0.21 | 4.04 | (0.30~0.86) | < 0.001 |  | |
 3 | Sexa | 19.71 | 2.72 | 0.42 | 7.23 | (14.34~25.08) | < 0.001 | 0.332 |
Age | 0.71 | 0.14 | 0.26 | 4.80 | (0.42~1.01) | < 0.001 |  | |
SOS | 0.15 | 0.05 | 0.17 | 2.92 | (0.50~0.25) | 0.004 | Â | |
 4 | Sexa | 18.91 | 2.73 | 0.40 | 6.91 | (13.52~24.29) | < 0.001 | 0.342 |
Age | 0.75 | 0.14 | 0.28 | 5.06 | (0.46~1.05) | < 0.001 |  | |
SOS | 0.14 | 0.05 | 0.15 | 2.64 | (0.03~0.24) | 0.009 | Â | |
TRACP5b | −0.02 | 0.01 | −0.11 | −2.10 | (−0.03~ − 0.001) | 0.037 |  | |
(b) OC as dependent variable | ||||||||
 1 | TRACP-5b | 0.03 | 0.003 | 0.63 | 12.78 | (0.03~0.04) | < 0.001 | 0.404 |
 2 | TRACP-5b | 0.03 | 0.003 | 0.60 | 12.15 | (0.03~0.04) | < 0.001 | 0.428 |
Sexa | −2.73 | 0.81 | −0.16 | −3.36 | (−4.33~ − 1.13) | 0.001 |  | |
 3 | TRACP-5b | 0.03 | 0.003 | 0.62 | 12.46 | (0.03~0.04) | < 0.001 | 0.438 |
Sexa | −2.49 | 0.81 | −0.15 | −3.06 | (−4.09~ − 0.89) | 0.002 |  | |
Age | −0.10 | 0.04 | −0.11 | −2.23 | (−0.19~ − 0.01) | 0.026 |  | |
(c) IGF-1 as dependent variable | ||||||||
 1 | Age | −1.03 | 0.22 | −0.29 | −4.68 | (−1.47~ − 0.60) | < 0.001 | 0.080 |
 2 | Age | −0.88 | 0.22 | −0.24 | −3.93 | (−1.32~ − 0.42) | < 0.001 | 0.107 |
SOS | 0.21 | 0.07 | 0.17 | 2.85 | (0.06~0.35) | 0.005 | Â | |
 3 | Age | −0.86 | 0.22 | −0.24 | −3.87 | (−1.30~ − 0.42) | < 0.001 | 0.124 |
SOS | 0.19 | 0.07 | 0.16 | 2.60 | (0.04~0.33) | 0.010 | Â | |
BMI | 1.58 | 0.66 | 0.14 | 2.38 | (0.27~2.89) | 0.018 | Â |